Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Balance Sheets

v3.22.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,053 $ 760
Accounts receivable and contract assets, net of allowance for credit losses of $28 million and $28 million, respectively 205 142
Income taxes receivable (note 7) 1 48
Other current assets 44 26
Total current assets 1,303 976
Property and equipment, at cost (note 2) 261 259
Accumulated depreciation (158) (141)
Property and equipment, net 103 118
Intangible assets not subject to amortization (note 4):    
Goodwill 2,200 2,220
Trademarks 726 730
Intangible assets not subject to amortization 2,926 2,950
Intangible assets subject to amortization, net (note 4) 112 133
Other assets, at cost, net of accumulated amortization 194 199
Total assets 4,638 4,376
Current liabilities:    
Deferred merchant and other payables 242 140
Deferred revenue 44 36
Accrued liabilities and other current liabilities 248 180
Total current liabilities 534 356
Long-term debt, including $237 million and $268 million measured at fair value as of December 31, 2022 and December 31, 2021, respectively (note 5) 1,125 1,143
Deferred income tax liabilities (note 7) 120 144
Financial instrument liabilities (note 3) 30 85
Series A Preferred Stock liability (note 8) 230 212
Other liabilities 337 309
Total liabilities 2,376 2,249
Equity:    
Additional paid-in capital 287 288
Accumulated other comprehensive earnings (loss), net of taxes 9 (21)
Retained earnings (deficit) (439) (469)
Total stockholders' equity (142) (201)
Noncontrolling interests in equity of subsidiaries 2,404 2,328
Total equity 2,262 2,127
Commitments and contingencies (note 12)
Total liabilities and equity 4,638 4,376
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value